Passivating the Omicron SARS-CoV-2 variant with self-assembled nano peptides: Specificity, stability, and no cytotoxicity

Alaa F. Nahhas, Thomas J. Webster

Open source

DOI
10.1016/j.onano.2022.100054
Published
2022-07
Container
OpenNano
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.onano.2022.100054,
  title = {Passivating the Omicron SARS-CoV-2 variant with self-assembled nano peptides: Specificity, stability, and no cytotoxicity},
  author = {Alaa F. Nahhas and Thomas J. Webster},
  year = {2022},
  journal = {OpenNano},
  doi = {10.1016/j.onano.2022.100054},
  url = {https://doi.org/10.1016/j.onano.2022.100054}
}

RIS

TY  - JOUR
TI  - Passivating the Omicron SARS-CoV-2 variant with self-assembled nano peptides: Specificity, stability, and no cytotoxicity
AU  - Alaa F. Nahhas
AU  - Thomas J. Webster
PY  - 2022
JO  - OpenNano
DO  - 10.1016/j.onano.2022.100054
UR  - https://doi.org/10.1016/j.onano.2022.100054
ER  - 

APA

Nahhas, A. F., & Webster, T. J. (2022). Passivating the Omicron SARS-CoV-2 variant with self-assembled nano peptides: Specificity, stability, and no cytotoxicity. OpenNano. https://doi.org/10.1016/j.onano.2022.100054

Source records